Jeanette H. Andersen

Jan 1, 2024 | ard.bmj.com | Antonis Fanouriakis |Myrto Kostopoulou |Jeanette H. Andersen |Martin Aringer

Handling editor David S PisetskyTwitter @cmukhtyar, @edvital, @chriswincup, @george_bertsias, @noneContributors AF and MK reviewed the literature and AF drafted the manuscript. GB and CBM supervised the methodology. All authors edited the manuscript. DTB supervised the project. Funding European League against Rheumatism (project number QoC015).

Jan 1, 2024 | ard.bmj.com | Antonis Fanouriakis |Myrto Kostopoulou |Jeanette H. Andersen |Martin Aringer

Dear Editor,The 2023 update of the EULAR recommendations for the management of systemic lupus erythematosus (SLE) recommend hydroxychloroquine (HCQ) for all patients with SLE at a target dose of 5 mg/kg real body weight (RBW)/day but also suggest individualizing the regimen in accordance with the risk of flares or retinal toxicity.

Oct 12, 2023 | ard.bmj.com | Antonis Fanouriakis |Myrto Kostopoulou |Jeanette H. Andersen |Martin Aringer

DiscussionFor these recommendations, we assembled a Task Force of world-leading experts in the field of SLE from four continents, to assure the widest possible representation and broad expertise. This is particularly important, because SLE across the world is very different in terms of presentation and severity.